NCT03352115

Brief Summary

Tonsillectomy is one of the most common surgical procedures in the United States, and post-operative pain management is a challenge for otolaryngologists. A 2013 black-box warning on codeine following tonsillectomy has drawn attention to potential concerns with all narcotics in these patients, and many surgeons try to avoid narcotics. The use of intra-operative corticosteroids has been proven to be beneficial in reducing post-operative morbidity, and some small studies have shown possible benefit to the use of post-operative oral corticosteroids as well, although the results of these studies are mixed. To date, no one has looked at whether the use of post-operative oral steroids may reduce or eliminate the need for narcotics. We aim to determine whether the addition of oral steroids to our post-operative pain regimen can reduce the need for narcotic pain medications.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 24, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

November 24, 2017

Status Verified

November 1, 2017

Enrollment Period

1 year

First QC Date

November 20, 2017

Last Update Submit

November 22, 2017

Conditions

Outcome Measures

Primary Outcomes (4)

  • narcotics uses

    total amount of narcotic medication used in post-op period

    1 week

  • non-narcotic pain medication used

    amount of acetaminophen and ibuprofen needed post-operatively

    1 week

  • diet

    time to return to normal diet

    1 week

  • activity

    time to return to normal activity level

    1 week

Secondary Outcomes (3)

  • ED visits

    1 week

  • dehydration

    1 week

  • hemorrhage

    1 week

Study Arms (2)

Steroid group

EXPERIMENTAL

Will recieve 5 day course of oral prednisolone post-operatively

Drug: Prednisolone

Control

PLACEBO COMPARATOR

Will receive placebo syrup for 5 days post-operatively

Drug: Placebos

Interventions

5 day course of oral prednisolone

Steroid group

Placebo syrup

Control

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Subject is male or female age 4-18 years of age
  • Patients undergoing total tonsillectomy with or without adenoidectomy or tympanostomy tubes
  • Patients with obstructive sleep apnea or recurrent tonsillitis requiring tonsillectomy.
  • The patient or caregiver is able to provide written informed consent.
  • Patients with American Society of Anesthesiologist (ASA) physical status 1 or 2.

You may not qualify if:

  • Subjects with complex medical conditions or craniofacial abnormalities
  • Subjects with known personal or family history of bleeding disorder
  • Subjects with cognitive or developmental disorders
  • Subjects currently taking corticosteroids for other medical conditions, or who have taken corticosteroids within 2 weeks of surgery
  • Subjects who are wards of the state
  • Subjects who have had an organ transplant
  • Subjects who are on other immunosuppressant medications
  • Subjects with diabetes mellitus
  • Non-English Speakers or English as a second language
  • Subjects undergoing intracapsular tonsillectomy
  • Subjects with American Society of Anesthesiologist (ASA) physical status greater than 2.
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Prednisolone

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic Compounds

Central Study Contacts

Bianca Siegel, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 20, 2017

First Posted

November 24, 2017

Study Start

January 1, 2018

Primary Completion

January 1, 2019

Study Completion

January 1, 2019

Last Updated

November 24, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share